Phenylpropanolamine and vasospasm
Traynelis, V.C.; Brick, J.F.
Neurology 36(4): 593-594
1986
ISSN/ISBN: 0028-3878 PMID: 3960341 Document Number: 273081
Document emailed within 1 workday
Related Documents
Nishizawa, Y. 1993: The pathogenesis and the preventive treatment of cerebral vasospasm following subarachnoid hemorrhage--especially clinical and pharmacological effect of Ca++ antagonist for vasospasm Nihon Rinsho. Japanese Journal of Clinical Medicine 51 Suppl: 389-396Niizuma, H.; Kwak, R.; Ohi, T.; Katakura, R.; Mizoi, K.; Suzuki, J. 1978: The angiographical study on cerebral vasospasm following the rupture of intracranial aneurysm (1st report).--Time relationship between vasospasm on angiography and the onset of subarachnoid hemorrhage (aurhor's transl) No Shinkei Geka. Neurological Surgery 6(8): 749-755
Silverman, H.I.; Shargel, L. 1986: Phenylpropanolamine American Family Physician 34(4): 39-42
Widerlöv, E. 1979: Phenylpropanolamine-induced psychoses Lakartidningen 76(49): 4529-4530
Lake, C.R.; Rosenberg, D.; Quirk, R. 1990: Phenylpropanolamine and caffeine use among diet center clients International Journal of Obesity 14(7): 575-582
Lönnerholm, G.; Grahnén, A.; Lindström, B. 1984: Steady-state kinetics of sustained-release phenylpropanolamine International Journal of Clinical Pharmacology Therapy and Toxicology 22(1): 39-41
Ryu, S.J.; Lin, S.K. 1995: Cerebral arteritis associated with oral use of phenylpropanolamine: report of a case Journal of the Formosan Medical Association 94(1-2): 53-55
Bende, M.; Andersson, K.E.; Johansson, C.J.; Sjögren, C.; Svensson, G. 1985: Vascular effects of phenylpropanolamine on human nasal mucosa Rhinology 23(1): 43-48
Lehtonen, T.; Rannikko, S.; Lindell, O.; Talja, M.; Wuokko, E.; Lindskog, M. 1986: The effect of phenylpropanolamine on female stress urinary incontinence Annales Chirurgiae et Gynaecologiae 75(4): 236-241
Thomas, M.; Scheinmann, N. 1977: Evanescent toxic thyroid adenoma. Possible role of phenylpropanolamine La Semaine des Hopitaux: Organe Fonde Par l'Association d'Enseignement Medical des Hopitaux de Paris 53(34-35): 1863-1865
Larson, W.L.; Rogers, A. 1986: Overdosage from phenylpropanolamine: experience of the Hennepin Regional Poison Center Veterinary and Human Toxicology 28(6): 546-548
Castellani, S. 1985: Catatonia associated with phenylpropanolamine overdose and fluphenazine treatment: case report Journal of Clinical Psychiatry 46(7): 288-289
Morgan, J.P.; Funderburk, F.R. 1990: Invited commentary: phenylpropanolamine and the medical literature: a thorough reading is required International Journal of Obesity 14(7): 569-574
Jessen, T.G.; Martinez, T.T. 1987: The effect of phenylpropanolamine and amphetamine on fighting behavior and weight change in mice Proceedings of the Western Pharmacology Society 30: 419-422
Dowse, R.; Scherzinger, S.S.; Kanfer, I. 1990: Serum concentrations of phenylpropanolamine and associated effects on blood pressure in normotensive subjects: a pilot-study International Journal of Clinical Pharmacology Therapy and Toxicology 28(5): 205-210
Sands, C.D.; Jung, K.M.; Jones, D.W.; Kim, H.J. 1992: Effect of phenylpropanolamine hydrochloride on blood pressure in Korean patients with hypertension controlled by hydrochlorothiazide Clinical Pharmacy 11(2): 168-173
Segal, A.T.; Falliers, C.J.; Grant, J.A.; Podleski, W.K.; Woehler, T.R.; Huster, W.J.; McNutt, B. 1993: Safety and efficacy of terfenadine/pseudoephedrine versus clemastine/phenylpropanolamine in the treatment of seasonal allergic rhinitis Annals of Allergy 70(5): 389-394
Chung, Y.T.; Hung, D.Z.; Hsu, C.P.; Yang, D.Y.; Wu, T.C. 1998: Intracerebral hemorrhage in a young woman with arteriovenous malformation after taking diet control pills containing phenylpropanolamine: a case report Zhonghua Yi Xue Za Zhi 61(7): 432-435
Addonizio, V.P.; Harken, A.H.; Goldberg, S. 1983: Postoperative coronary vasospasm Cardiovascular Clinics 14(1): 111-121
Joyal, D.; Charbonneau, Fçois. 2003: Vasospasm and myocardial bridge Canadian Journal of Cardiology 19(12): 1440-1442